Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors
ClinicalTrials.gov study NCT04158648. IPD Sharing: YES. Countries: 10. Publications: 1.
Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03989349. IPD Sharing: NO. Countries: 11. Publications: 3.
Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
ClinicalTrials.gov study NCT03014635. IPD Sharing: NO. Countries: 2. Publications: 2.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT00783692. IPD Sharing: Not stated. Countries: 3. Publications: 9.
Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment
ClinicalTrials.gov study NCT03289208. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis
ClinicalTrials.gov study NCT00800982. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
ClinicalTrials.gov study NCT01202903. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19
ClinicalTrials.gov study NCT06676709. IPD Sharing: YES. Countries: 1. Publications: 26.
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness
ClinicalTrials.gov study NCT04634409. IPD Sharing: YES. Countries: 3. Publications: 4.
A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma
ClinicalTrials.gov study NCT01311661. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19
ClinicalTrials.gov study NCT04779879. IPD Sharing: Not stated. Countries: 5. Publications: 2.
A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis
ClinicalTrials.gov study NCT00267969. IPD Sharing: Not stated. Countries: 3. Publications: 2.
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
ClinicalTrials.gov study NCT02038829. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With a Next-Generation Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT05573464. IPD Sharing: YES. Countries: 9. Publications: 1.
A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis
ClinicalTrials.gov study NCT01483599. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
ClinicalTrials.gov study NCT02905331. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
ClinicalTrials.gov study NCT05225415. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye
ClinicalTrials.gov study NCT01657253. IPD Sharing: NO. Countries: 1. Publications: 1.
Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
ClinicalTrials.gov study NCT02858726. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics
ClinicalTrials.gov study NCT00634036. IPD Sharing: Not stated. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.